UK markets closed

Pfizer Inc. (0Q1N.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
50.83+0.25 (+0.49%)
At close: 07:12PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.57
52-week change 3-24.00%
S&P500 52-week change 322.38%
52-week high 354.90
52-week low 333.27
50-day moving average 335.66
200-day moving average 340.39

Share statistics

Avg vol (3-month) 3236.99k
Avg vol (10-day) 367.86k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 85.64B
% held by insiders 10.05%
% held by institutions 170.10%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 31.65
Trailing annual dividend yield 33.26%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 301 Jul 1999

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -0.56%
Operating margin (ttm)31.52%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)54.89B
Revenue per share (ttm)9.72
Quarterly revenue growth (yoy)-18.60%
Gross profit (ttm)N/A
EBITDA 9.44B
Net income avi to common (ttm)-288M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)-43.80%

Balance sheet

Total cash (mrq)12.69B
Total cash per share (mrq)2.25
Total debt (mrq)75.33B
Total debt/equity (mrq)84.37%
Current ratio (mrq)N/A
Book value per share (mrq)15.77

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A